Already have an ACS ID? Log in
Renew your membership, and continue to enjoy these benefits.
Already an ACS Member? Log in here
Choose the membership that is right for you. Discount will be applied automatically at checkout.
Enjoy these benefits no matter which membership you pick.
Most Popular in Pharmaceuticals
Ash Stevens will manufacture 5-azacitidine, the active ingredient in Pharmion's Vidaza, a recently approved treatment for the blood cancer myelodysplastic syndromes. According to Ash Stevens CEO Stephen A. Munk, his firm developed 5-azacitidine in partnership with its discoverer, the National Cancer Institute. Ash Stevens recently received FDA approval to make bortezomib, the active ingredient in Millennium Pharmaceutical's bone marrow cancer drug Velcade, and Munk expects approval later this year to make clofarabine, the active ingredient in Genzyme's Clofarex, a pediatric leukemia drug.
This article has been sent to the following recipient: